Digest Network Come funziona
Network
/
Società
Gu
Non verificato

Guardant Health, Inc.

Di cosa scriviamo

BiotecnologiaIndustriaOncologiaSaluteSanità

113 comunicati stampa

Guarda tutti i comunicati
16/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Attrezzature medico-sanitarie
Salute
Oncologia
Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
30/03/2026
Industria
Oncologia
Salute
Tecnica
Medicina - Varie
Farmaceutica
Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
18/03/2026
Eventi
Industria
Biotecnologia
Salute
Farmaceutica
Oncologia
Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
16/03/2026
Tecnica
Igiene alimentare
Associazioni/Professionisti
Salute
Oncologia
Software
Assicurazioni
Finanza
Mercato del lavoro
Industria
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
13/03/2026
Analisi di mercato
Industria
Oncologia
Salute
Biotecnologia
Sanità
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
10/03/2026
Mercato del lavoro
Industria
Oncologia
Salute
Sanità
Management
Biotecnologia
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
04/03/2026
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
03/03/2026
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
27/02/2026
Mercato azionario
Finanza
Sanità
Salute
Oncologia
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0
19/02/2026
Biotecnologia
Attrezzature medico-sanitarie
Salute
Oncologia
Web e Social Network
Telefonia e Varie
Mercato azionario
Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
Fonte
Guardant Health, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0